Category: Medications

The hidden bias in how we treat chronic pain

As a health care writer and data analyst, I hear frequently from patients who are being denied safe and effective pain care due to unscientific bias on the part of U.S. health care agencies—and sometimes on the part of otherwise once-reputable medical …

Biologics are not small molecules: the case for pre-allergy testing in an era of immune-based therapies

“Once it’s in your body, there’s no taking it back.” That’s what the infusion nurse told a friend of mine after administering the injection. She had just started a biologic medication for an autoimmune condition. Immediate…

Why the FDA’s outdated prescription rules hinder access to birth control and naloxone [PODCAST]

Subscribe to The Podcast by KevinMD. Watch on YouTube. Catch up on old episodes! Surgeon and author Jeffrey A. Singer discusses his article “The FDA’s outdated prescription rules are failing women and opioid users.” He argues that the…

Reforming the 340B drug discount program through data, clarity, and collaboration [PODCAST]

Subscribe to The Podcast by KevinMD. Watch on YouTube. Catch up on old episodes! Health care executive Gavin Magaha discusses his article “Advancing drug discount programs starts with collaboration and clarity.” He outlines how the 340B dru…

How America became overmedicated—and what we can do about it

In a revealing snapshot of American mental health, the CDC recently reported that nearly 1 in 4 adults in the United States may be taking psychotropic medications. This staggering number should both draw attention and raise questions. Are we truly addr…

The FDA’s outdated prescription rules are failing women and opioid users

An excerpt from Your Body, Your Health Care. Tens of millions of American women—more than four out of five women who have had sexual intercourse—have used oral contraceptives, which are crucial for reducing unwanted pregnancies and the incidence of abo…

Big pharma’s grip on health care: time for change

Everyone seems so scared of the word government regulation when it comes to health care. Why? In part, this is because those against regulations (everyone making money off health care) make sure to scare laypeople into equating such action with sociali…

Advancing drug discount programs starts with collaboration and clarity

The 340B drug discount program was enacted more than 30 years ago to lower the cost of medications so providers could deliver more comprehensive services for vulnerable patients. As care delivery has evolved greatly over that time, the program has not …

You could soon be taking (or prescribing) a drug developed by AI

Across all industries, artificial intelligence is changing our approach to developing new products, including in the life sciences and drug development. While it may seem that an AI-derived treatment is far in the future, the science, biomathematics, a…

How the Medicare Prescription Payment Plan provides a practical solution to medication nonadherence

Starting January 1, 2025, the Medicare Prescription Payment Plan (MPPP) will give providers a powerful way to address one of the biggest barriers to effective care: cost-related medication nonadherence. With 54 million Medicare beneficiaries eligible, …